The Department of Pharmacology is delighted to announce that Kevin Young CBE has made a sizable donation to the Department. Professor Frances Platt FRS FMedSci said, “This is one of the largest donations in the hundred-year history of the Department and we were also delighted that Mr Young joined our community as a Senior Research Fellow last year. His insight and experience in drug discovery will be greatly valued by the Department and the Medical Sciences Division.”
Kevin has worked for over 35 years in Biopharma, including ICI Pharmaceuticals, Amgen and Gilead. He retired in February 2018 as Chief Operating Officer with Gilead Sciences. During his tenure, Gilead transformed the treatment of multiple viral diseases, notably HIV, Hepatitis B, Hepatitis C and Influenza.
Kevin has degrees in Sports Science and Exercise and has 18 publications in human muscle physiology to his name. Originally from York, England, Kevin resides on the West Coast of the USA.
In 2011, Kevin was appointed ‘Commander of The Most Excellent Order of the British Empire’ in recognition of his contributions to the Biopharma Industry and Healthcare.
We are extremely grateful for his most generous gift and his membership of our community in Oxford.